Search - tctmd.com

Displaying 221 - 229 of 229

Sort: Relevancy | Date

Presentation TCT 2012

Hemodynamics and Interactive Calculations for Aortic Stenosis Using the "John Madden" Telestrator

Presenter: Tim Lapp

October 22, 2012

Presentation TCT 2012

Aortic Valve Disease Hemodynamics and Intervention with Approved Devices (Including Related Guidelines)

Presenter: Susheel Kodali

October 22, 2012

Presentation TCT 2012

Hemodynamics for "Dummies:" A Novel iPad Application for Medical Education, Patient Selection, and Device Development

Presenter: Daniel Burkhoff

October 22, 2012

Presentation TCT 2012

Right Heart Catheterization: Technique and Hemodynamics

Presenter: Robert Pyo

October 21, 2012

Presentation TCT 2012

Left Heart Catheterization: Technique and Hemodynamics

Presenter: Duane Pinto

October 21, 2012

Presentation TCT 2012

Cost-effectiveness and Clinical Outcomes of Impella Hemodynamic Support Compared with Intra- Aortic Balloon Pump in High Risk Patients Receiving PCI: Results from the PROTECT II Trial

Presenter: Brijeshwar Maini, William O?Neill, Simon Dixon, Igor Palacios, Theodore Schreiber, David A. Gregory, D. J. Scotti

January 03, 2012

News Conference News

PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years

November 09, 2011

News Conference News

Mitral, Aortic Regurgitation Increase Mortality After Transcatheter Valve Replacement

November 08, 2011

Video

Lifetime Patient Management and the Importance of TAVR Hemodynamics

October 27, 2022

Advertisement

Hemodynamics and Interactive Calculations for Aortic Stenosis Using the "John Madden" Telestrator

Aortic Valve Disease Hemodynamics and Intervention with Approved Devices (Including Related Guidelines)

Hemodynamics for "Dummies:" A Novel iPad Application for Medical Education, Patient Selection, and Device Development

Right Heart Catheterization: Technique and Hemodynamics

Left Heart Catheterization: Technique and Hemodynamics

Cost-effectiveness and Clinical Outcomes of Impella Hemodynamic Support Compared with Intra- Aortic Balloon Pump in High Risk Patients Receiving PCI: Results from the PROTECT II Trial

PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years

Mitral, Aortic Regurgitation Increase Mortality After Transcatheter Valve Replacement

Lifetime Patient Management and the Importance of TAVR Hemodynamics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content